Focus Stocks
Goodyear Closing in to Resistance
Published on Thursday, 09 February 2012 05:56 Written by TradersHuddle Wire
New York, February 9th (TradersHuddle.com) - Shares of The Goodyear Tire & Rubber Company (NYSE:GT) are trading very close to calculated resistance at $13.96 with the current price action closing at just $13.95 placing the stock near levels that make it difficult to buy.
The Goodyear Tire & Rubber Company (NYSE:GT) main activities are to develop, manufacture, market and distribute tires and rubber products. The products include lines of power transmission belts, hoses, rubber products for transportation industry and rubber-related chemicals for various applications. The company
Related Articles
- Goodyear Is Close to Resistance
- Goodyear Promotes Tire Care During Holiday Weekend, Safety Week
- Trading Idea: Key levels for Goodyear
- Goodyear's Laura Thompson Named Outstanding Woman In Finance
- Will Goodyear recover?
- Goodyear is Near a Key Support Area
- Goodyear to Receive Manny Award for Zero Waste to Landfill Program
- Goodyear Tops 'Fortune 500' List for Northeast Ohio
- Goodyear Is Approaching its 50 Day Moving Average
- Critical Alerts For Netflix, EnCana, Western Digital, Goodyear, and Skechers Released By InvestorsObserver
Related Partner Headlines
- Goodyear Tire: S&P Intraday Gainer - TheStreet.com
- Goodyear Tire & Rubber Co (GT): Today's Featured Consumer Goods Winner - TheStreet.com
- Goodyear Tire & Rubber Co (GT): Today's Featured Consumer Non-Durables Loser - TheStreet.com
- Jeff Middleswart: Goodyear Will Declare Bankruptcy - Benzinga
- Goodyear Will Redeem $650M in Senior Notes - Benzinga
- Goodyear Announces Pricing of $700 Million of Senior Notes - Benzinga
- UPDATE: Citigroup Lowers Target on Goodyear to $21 - Benzinga
- UPDATE: Deutsche Bank Cuts Target on Goodyear to $20 - Benzinga
- Goodyear Tire & Rubber Stock Falls On Unusually High Volume (GT) - TheStreet.com
- UPDATE: Goodyear Swings To Q4 Profit - Benzinga
Volatile market? That's when profit potential skyrockets for options traders. Now you can get up to 50 trade opportunities a week from top options experts -- plus much more -- on our exciting new site OptionsProfits.
Try it FREE!
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Recent Trading Ideas
Latest Partner Headlines
-
Coming Week: Top Nine Earnings on Deck - TheStreet.com -
Something's Not Right in the Video-Game Space - TheStreet.com -
For Ambitious Students, Entrepreneurship Can Be a Big Win - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com -
Toyota Is Back as May Sales Continue Auto Industry Recovery - TheStreet.com
Stock Market
Loading
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis -
SunOpta Enters Into Agreement to Divest Its Canadian Based Natural Health Products Business -
PC Connection, Inc. (PCCC) To Present at The SeeThruEquity First Annual Small Cap Investor Conference on Tuesday, June 5, 2012 -
Aeroflex Announces Amendment to Credit Agreement -
Alliance Data to Participate at Upcoming Investor Conferences -
PCA3 Test Featured at American Urological Association Meeting -
MOCON Announces Quarterly Dividend -
Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus









